Pharmaceutical Care Program for Pharmacological Treatment of Depression in Primary Care (PRODEFAR)

Fundació Sant Joan de Déu

Status: Completed

Conditions: Depression

Treatments: Behavioral: Pharmaceutical care program for antidepressant treatment

Study type: Interventional

Funder types: Other

Identifiers

NCT00794196

FIS PI070546

Details and patient eligibility

About

The purpose of this study is to evaluate the impact of pharmaceutical services among patients starting a treatment with antidepressants for a diagnosis of depression. The hypothesis of the study is that pharmacist intervention can improve compliance to antidepressants and patient wellbeing.

Full description

The aim of this study is to evaluate the efficacy of a support program in community pharmacy on the improvement of the compliance to antidepressants and the clinic of typical primary care patients under normal practice circumstances. That implies that the intervention is made by pharmacists without any specific requirement that work in the community pharmacies set up in the area of study and on patients following the usual medical circuit. As well, the cost of the support program is calculated in order to set the effectiveness of the program.

Enrollment: 179 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis for depression from a general practitioner
• Beginning a pharmacological antidepressant treatment
• Going to one of the participant community pharmacies

Exclusion criteria

• Used antidepressant medication in the past 2 months
• Had an appointment with an specialist in mental disorders in the past 2 months
• History of psychotic or bipolar episodes
• History of drug abuse or dependency
• Cognitive impairment that not allows assessment

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

179 participants in 2 patient groups

Usual Care

No Intervention group

Description:

The control group will be receiving usual medical and pharmaceutical care.

Intervention Group

Experimental group

Description:

Intervention group will be receiving usual medical and pharmaceutical care plus a pharmaceutical support program.

Treatment:

Behavioral: Pharmaceutical care program for antidepressant treatment